Transitional Period

Federal departments are moving their web content to Canada.ca. As a part of that process, proactive disclosure reports will become available through the Open Government portal.  During this transition, if a proactive disclosure report from a specific department is not yet available on the Open Government portal please refer to Proactive disclosure by department or agency where a copy can be found.  For any questions on this issue, please contact us at open-ouvert@tbs-sct.gc.ca .

Completed Access to Information Requests

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests previously made to the Government of Canada. If you find a summary of interest, you can request a copy of the records at no cost. For additional information, please see the “About Access to Information Requests” webpage.

Download datasets of the summaries of completed access to information requests.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator.

Enter keywords (e.g. institution, topic, field of interest, etc.)
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Follow:

Search Results

Displaying 1 - 10 of 1119

Request Number: A-2017-000682

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 2

Request Summary: Adverse Reaction Report (AER) for Fluzone Quadrivalent. Report number: 000688528.

Make an informal request for: A-2017-000682 (HC)

Request Number: A-2015-000021

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 70

Request Summary: All information concerning the licence application for Voltaren Emulgel for joint pain.

Make an informal request for: A-2015-000021 (HC)

Request Number: A-2015-000027

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 163

Request Summary: All information concerning the licence application for PregVit.

Make an informal request for: A-2015-000027 (HC)

Request Number: A-2017-000683

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 8

Request Summary: Adverse Reaction Report (AER) for Pediacel. Report numbers: 000687807, 000689233, 000689269.

Make an informal request for: A-2017-000683 (HC)

Request Number: A-2017-000680

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 9

Request Summary: Adverse Reaction Report (AER) for Eligard. Report number: 000687413.

Make an informal request for: A-2017-000680 (HC)

Request Number: A-2017-000042

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 22

Request Summary: Adverse Reaction Report (AER) for furosemide . Report number: E2B_00547501.

Make an informal request for: A-2017-000042 (HC)

Request Number: A-2017-000040

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 15

Request Summary: Adverse Reaction Report (AER) for nitroglycerin. Report numbers: 000667764, E2B_00579268.

Make an informal request for: A-2017-000040 (HC)

Request Number: A-2016-001739

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 10

Request Summary: Adverse Reaction Report (AER) for metformin hydrochloride. Report number: E2B_00434165.

Make an informal request for: A-2016-001739 (HC)

Request Number: A-2014-000154

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 418

Request Summary: Submissions made to the Public Consultation on the Notification of Drug Shortages.

Make an informal request for: A-2014-000154 (HC)

Request Number: A-2017-000508

Organization: Health Canada

Disposition: Disclosed in part

Year: 2017

Month: August

Number of Pages: 33

Request Summary: Adverse Reaction Report (AER) for insulin glargine. Report numbers: E2B_00856528, 000680986, 000678211, 000681478.

Make an informal request for: A-2017-000508 (HC)

Current Search

Organization

Year

Month